22 results
S-3
EX-1.2
ALGS
Aligos Therapeutics Inc
4 Nov 21
Shelf registration
4:57pm
unauthorized use, access, misappropriation or modification (“Data Security Obligations”). Neither the Company nor any of its subsidiaries have … received any notification of or complaint regarding non-compliance with any Data Security Obligation, and there is no pending or, to the knowledge
10-Q
2020 Q3
ALGS
Aligos Therapeutics Inc
25 Nov 20
Quarterly report
5:21pm
, provide robust disclosures to individuals, accommodate a set of individual data rights, provide data security breach notifications within 72 hours after … . Failure to comply with the GDPR and other countries’ privacy or data security-related laws, rules or regulations could result in material penalties
10-K
3pwm33 6sg
23 Mar 21
Annual report
4:26pm
424B4
rril p1lf3
1 Jul 21
Prospectus supplement with pricing info
4:31pm
424B4
jkyz3vf41
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1
1ba 6h6ggu
25 Sep 20
IPO registration
5:27pm
DRS
6ozvp
4 Jun 21
Draft registration statement
12:00am
DRS
aih190os4n0kihl
26 Aug 20
Draft registration statement
12:00am